Answer
Nevirapine prolonged-release tablets are indicated with other antiretroviral medicines to treat HIV-1 infection in adults, adolescents and children aged three years and above who can swallow tablets; they are not suitable for the initial 14-day lead-in phase.
Sources for this answer
- Nevirapine 400 mg prolonged-release tabletsAmarox Limited · emc · SmPC §4.1 Therapeutic Indications · Version 2Document updated
Sources checked